Keeping you up to dateLatest Clearstate Healthcare Insights postsClearstate Insights is your single source to all our latest healthcare intelligence. From recently published reports offering thought-provoking analysis, to information about new products and services, we will ensure you are always kept informed. Sign up to Clearstate’s newsletter
2024年のヘルスケア業界の展望とトレンド 2024年、世界経済の回復は医療業界の出費が再び成長の兆しに戻ることを示唆する。… Centralised Diagnostics (CEDx) | Covid-19 testing | General surgery | In-vitro diagnostics | Infectious Diseases Testing Monitor | Next Generation Sequencing (NGS) | Surgical device | Global
Essential insights into Vietnam’s in-vitro diagnostics market Vietnam’s IVD market, estimated at US$419.2m, faced a… Centralised Diagnostics (CEDx) | In-vitro diagnostics | Infectious Diseases Testing Monitor | Point-of-care testing (POCT) | Asia | Vietnam
Healthcare outlook 2024 A recovery in the global economy will cause a return to… Cardiovascular surgery | Centralised Diagnostics (CEDx) | Covid-19 testing | General surgery | In-vitro diagnostics | Infectious Diseases Testing Monitor | Next Generation Sequencing (NGS) | Surgical device | Global
Growth opportunities for IVD companies in APAC and LATAM Growth opportunities from covid-19 have helped fuel rapid… Centralised Diagnostics (CEDx) | In-vitro diagnostics | Point-of-care testing (POCT) | Tissue Diagnostics (TDx) | Americas | Asia
Building a market access blueprint for lung cancer diagnostics in Asia-Pacific Lung cancer is the leading cause of cancer mortality in the… Cancer diagnostics | Centralised Diagnostics (CEDx) | In-vitro diagnostics | Molecular Diagnostics (MDx) | Asia | Global | Centralised Diagnostics (CEDx) | IVD Gateway | Molecular Diagnostics (MDx)
Launching a new value proposition for core lab solutions An IVD multinational company is preparing to roll out a new… Centralised Diagnostics (CEDx) | In-vitro diagnostics | Americas | Asia | Europe | Global | Middle East & Africa | Centralised Diagnostics (CEDx) | IVD Gateway
How Indonesia’s healthcare transformation will impact its IVD market Indonesia’s in-vitro diagnostics (IVD) market will recover… Centralised Diagnostics (CEDx) | In-vitro diagnostics | Molecular Diagnostics (MDx) | Point-of-care testing (POCT) | Asia | Centralised Diagnostics (CEDx) | IVD Gateway | Molecular Diagnostics (MDx) | Point-of-care testing (POCT)
How inflation will impact Brazil’s IVD market Brazil’s in-vitro diagnostics (IVD) market will recover in… Centralised Diagnostics (CEDx) | In-vitro diagnostics | Molecular Diagnostics (MDx) | Point-of-care testing (POCT) | Uncategorised | Americas
Testing times: opportunities for IVD companies in 2023 Growth opportunities from covid-19 have helped fuel rapid… Centralised Diagnostics (CEDx) | In-vitro diagnostics | Point-of-care testing (POCT) | Tissue Diagnostics (TDx) | Americas | Asia | Europe | Global | Middle East & Africa
Going global: opportunities for Chinese IVD companies Opportunistic growth opportunities from covid-19 have helped… Centralised Diagnostics (CEDx) | In-vitro diagnostics | Molecular Diagnostics (MDx) | Point-of-care testing (POCT) | Middle East & Africa
Supporting the global launch of a clinical chemistry assay One of the largest IVD multinational companies plans to… Centralised Diagnostics (CEDx) | In-vitro diagnostics | Global | Centralised Diagnostics (CEDx) | IVD Gateway
How Vision 2030 is driving growth in Saudi Arabia’s IVD market The incidence of cardiovascular diseases (CVD) in… Centralised Diagnostics (CEDx) | In-vitro diagnostics | Molecular Diagnostics (MDx) | Point-of-care testing (POCT) | Middle East & Africa | Centralised Diagnostics (CEDx) | IVD Gateway | Molecular Diagnostics (MDx)
Sign up to our free newsletterThe latest trends and insights into the IVD and Surgical sectors, from our specialists and analysts, delivered directly to your inbox. Sign up to Clearstate’s newsletter today. Sign up now